Details of the Drug Reposition

General Information of This Drug (ID: DMD02QS)

Drug Name
Eupatilin   DMD02QS
Synonyms
22368-21-4; Euptailin; CHEBI:4932; 5,7-Dihydroxy-3',4',6-trimethoxyflavone; UNII-4D58O05490; CHEMBL312750; DRRWBCNQOKKKOL-UHFFFAOYSA-N; 2-(3,4-dimethoxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one; 4D58O05490; 2-(3,4-dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-chromen-4-one; 2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one; NSC 122413; AC1NRVK5; SCHEMBL1033509; Eupatilin, > DTXSID30176904; EBD1182; MolPort-008-155-866; ZINC6018691; HY-N0783; BCP09703; NSC122413; BDBM50060926; LMPK12111228
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic diarrhoea DISH3PX3 1A36.0Z Approved [1]
Pancreatitis DIS0IJEF DC31-DC34 Approved [1]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015